Creative Planning Tg Therapeutics, Inc. Transaction History

Creative Planning

$90.1 Billion
Q1 2024

A detailed history of Creative Planning transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 34,763 shares of TGTX stock, worth $636,510. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,763

Previous 28,805 20.68%

Holding current value

$636,510

Previous $491,000 7.54%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.02 - $21.3 $77,573 - $126,905	5,958 Added 20.68%	34,763 $528,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $21,249 - $59,834	3,181 Added 12.41%	28,805 $491,000
Q3 2023 Nov 16, 2023	SELL	$8.36 - $26.5 $12,322 - $39,061	-1,474 Reduced 5.44%	25,624 $214,000
Q2 2023 Jul 21, 2023	BUY	$15.48 - $35.0 $20,077 - $45,395	1,297 Added 5.03%	27,098 $673,000
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $9,933 - $18,779	971 Added 3.91%	25,801 $388,000

Q4 2022 Feb 10, 2023	SELL	$5.01 - $11.83 $1,092 - $2,578	-218 Reduced 0.87%	24,830 $293,000
Q3 2022 Nov 03, 2022	BUY	$4.57 - $8.4 $763 - $1,402	167 Added 0.67%	25,048 $148,000
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $93,054 - $265,231	24,881 New	24,881 $106,000
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $632,266 - $1.66 Million	-80,956 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.2 - $35.51 $831,683 - $1.94 Million	54,716 Added 208.52%	80,956 $1.54 Million
Q3 2021 Nov 10, 2021	BUY	$21.78 - $40.45 $133,075 - $247,149	6,110 Added 30.35%	26,240 $873,000
Q2 2021 Aug 04, 2021	BUY	$32.5 - $48.96 $286,942 - $432,267	8,829 Added 78.13%	20,130 $781,000
Q1 2021 Apr 30, 2021	BUY	$41.61 - $54.3 $76,978 - $100,455	1,850 Added 19.57%	11,301 $545,000
Q4 2020 Jan 29, 2021	BUY	$25.27 - $54.9 $238,826 - $518,859	9,451 New	9,451 $492,000
Q2 2018 Jul 20, 2018	SELL	$12.5 - $15.0 $132,012 - $158,415	-10,561 Closed	0 $0
Q1 2018 Apr 18, 2018	BUY	$8.7 - $16.8 $91,880 - $177,424	10,561 New	10,561 $150,000

Others Institutions Holding TGTX

# of Institutions

269

Shares Held

87.7M

Call Options Held

2.72M

Put Options Held

1.74M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $2.66B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Tg Therapeutics, Inc. Transaction History